Journal of Multiple Sclerosis and Neuroimmunology

Author index

Page Path

HOME
BROWSE ARTICLES
Author index

Floriane Deygas	1 Article
Original Article Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online June 30, 2025 DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25 PDF

Volume 16, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

7,558	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,086	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
3,684	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,562	Rituximab Treatment for Neuroimmunologic Disorders
2,917	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By 4	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By 1	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2025 by Korean Society of Neuroimmunology.